AZN:NYSE
AstraZeneca
$165.41
arrow_downward
-0.76%(-1.27) 1D
$164.21
arrow_downward
-0.73% (-1.20)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 16, 4:00:03 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AZN...
Buksan
$166.97
Mataas
$167.18
Mababa
$164.36
Mkt. cap
259.57B
Avg. na dami
2.97M
Dami
3.46M
Dividend
1.95%
Bawat tatlong buwang dividend
$0.81
Petsa ng ex-dividend
Ago 6, 2026
P/E ratio
24.73
Mataas nang 52-wk
$212.71
Mababa nang 52-wk
$80.48
EPS
$6.69
Beta
0.30
Mga natitirang share
1.55B
Bilang ng mga empleyado
96K
Buksan
$166.97
Mataas
$167.18
Mababa
$164.36
Mkt. cap
259.57B
Avg. na dami
2.97M
Dami
3.46M
Dividend
1.95%
Bawat tatlong buwang dividend
$0.81
Petsa ng ex-dividend
Ago 6, 2026
P/E ratio
24.73
Mataas nang 52-wk
$212.71
Mababa nang 52-wk
$80.48
EPS
$6.69
Beta
0.30
Mga natitirang share
1.55B
Bilang ng mga empleyado
96K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Yahoo Finance
·
2 oras ang nakalipas
Stocktwits Biotech Dealmaker: Gilead, AstraZeneca And Roche Chase Pipeline Expansion Over Buyouts
ad-hoc-news.de
·
10 oras ang nakalipas
AstraZeneca stock: RBC keeps GBp 14,500 target for AstraZeneca stock
Insider Monkey
·
10 oras ang nakalipas
AstraZeneca’s Shares Have Fallen, but Is 14.6x Forward Earnings a Buying Opportunity?
Kalkine Media
·
12 oras ang nakalipas
FTSE 100 AstraZeneca (LSE:AZN): Cancer Drugs Back Dividend
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Tungkol sa AstraZeneca
CEOPascal Soriot
Mga Empleyado96.1K
ItinatagAbr 6, 1999
HeadquartersCambridge, Cambridgeshire, United Kingdom
Sektor-
Websiteastrazeneca.com